Abstract

Background: We assessed whether differential efficacy of early combined immunosuppression (ECI) in comparison with conventional management (CM) is present in patients with Crohn disease (CD) according to disease location.

Tags

Colonic Diseases, Crohn's Disease, Drug Therapy, Early Combined Immunosuppression, Ileal Diseases, Immunosuppression Therapy, Treat-to-Target

Read More